Matches in Wikidata for { <http://www.wikidata.org/entity/Q92479915> ?p ?o ?g. }
Showing items 1 to 52 of
52
with 100 items per page.
- Q92479915 description "article scientifique publié en 2020" @default.
- Q92479915 description "artículu científicu espublizáu en xineru de 2020" @default.
- Q92479915 description "scientific article published on 07 January 2020" @default.
- Q92479915 description "wetenschappelijk artikel" @default.
- Q92479915 description "наукова стаття, опублікована 7 січня 2020" @default.
- Q92479915 name "Undermining Glutaminolysis Bolsters Chemotherapy While NRF2 Promotes Chemoresistance in KRAS-Driven Pancreatic Cancers" @default.
- Q92479915 name "Undermining Glutaminolysis Bolsters Chemotherapy While NRF2 Promotes Chemoresistance in KRAS-Driven Pancreatic Cancers" @default.
- Q92479915 type Item @default.
- Q92479915 label "Undermining Glutaminolysis Bolsters Chemotherapy While NRF2 Promotes Chemoresistance in KRAS-Driven Pancreatic Cancers" @default.
- Q92479915 label "Undermining Glutaminolysis Bolsters Chemotherapy While NRF2 Promotes Chemoresistance in KRAS-Driven Pancreatic Cancers" @default.
- Q92479915 prefLabel "Undermining Glutaminolysis Bolsters Chemotherapy While NRF2 Promotes Chemoresistance in KRAS-Driven Pancreatic Cancers" @default.
- Q92479915 prefLabel "Undermining Glutaminolysis Bolsters Chemotherapy While NRF2 Promotes Chemoresistance in KRAS-Driven Pancreatic Cancers" @default.
- Q92479915 P1433 Q92479915-599AD54E-1E6D-4242-9C8B-3700E226EC3D @default.
- Q92479915 P1476 Q92479915-0AE4049C-7819-4EE8-8A41-1F94BC59D231 @default.
- Q92479915 P2093 Q92479915-182CC401-FCD9-4670-B19E-D873A1E61F5C @default.
- Q92479915 P2093 Q92479915-2BC6F85E-23D8-47CD-ACBE-528C63F63D6D @default.
- Q92479915 P2093 Q92479915-2E894264-9556-4A66-A2E7-32EB6A56E30C @default.
- Q92479915 P2093 Q92479915-32B23DD1-7CD0-47DC-9F1E-AD1E2E5837F3 @default.
- Q92479915 P2093 Q92479915-5884F648-4414-4F8B-844A-736FD86F9002 @default.
- Q92479915 P2093 Q92479915-B820B1BC-8FC2-408D-B72A-0BD5B6A88723 @default.
- Q92479915 P2093 Q92479915-BE53636C-8D0B-4496-BA84-680D2C26ADD2 @default.
- Q92479915 P304 Q92479915-2AC83BCF-94C2-4E28-9F6C-9E1A6E4953AB @default.
- Q92479915 P31 Q92479915-16959B36-EBC2-48C4-BA6A-B00A9E752CE3 @default.
- Q92479915 P356 Q92479915-BE7E4347-833D-4C30-B050-676D44057229 @default.
- Q92479915 P433 Q92479915-EE6C3C0A-82DA-4FEE-84D0-BBF1954C3430 @default.
- Q92479915 P478 Q92479915-A1E85224-29DB-4EA2-A47D-E2E7E14A95DB @default.
- Q92479915 P50 Q92479915-0F400401-7C6B-4EDA-9D89-800525DEDEDB @default.
- Q92479915 P50 Q92479915-B40770FC-6A89-4726-BFCE-EF0D5B53ECF0 @default.
- Q92479915 P577 Q92479915-2A1ECC34-E41A-40B0-846F-B1187FD01AB3 @default.
- Q92479915 P698 Q92479915-39FFE8E5-D5FD-4BFB-A260-D99CECC1B43D @default.
- Q92479915 P932 Q92479915-3FBCF6D5-9236-4690-999A-5B51143FB5B0 @default.
- Q92479915 P356 0008-5472.CAN-19-1363 @default.
- Q92479915 P698 31911550 @default.
- Q92479915 P1433 Q326097 @default.
- Q92479915 P1476 "Undermining Glutaminolysis Bolsters Chemotherapy While NRF2 Promotes Chemoresistance in KRAS-Driven Pancreatic Cancers" @default.
- Q92479915 P2093 "Dwight V Nissley" @default.
- Q92479915 P2093 "Frank McCormick" @default.
- Q92479915 P2093 "Pavan P Adiseshaiah" @default.
- Q92479915 P2093 "Serguei V Kozlov" @default.
- Q92479915 P2093 "Suman Mukhopadhyay" @default.
- Q92479915 P2093 "Theresa M Guerin" @default.
- Q92479915 P2093 "William Burgan" @default.
- Q92479915 P304 "1630-1643" @default.
- Q92479915 P31 Q13442814 @default.
- Q92479915 P356 "10.1158/0008-5472.CAN-19-1363" @default.
- Q92479915 P433 "8" @default.
- Q92479915 P478 "80" @default.
- Q92479915 P50 Q55175640 @default.
- Q92479915 P50 Q59752046 @default.
- Q92479915 P577 "2020-01-07T00:00:00Z" @default.
- Q92479915 P698 "31911550" @default.
- Q92479915 P932 "7185043" @default.